iShares Neuroscience and Healthcare ETF Rating $39.37 -0.09 (-0.23%) Closing price 09/3/2026 04:10 PM EasternExtended Trading$39.37 +0.00 (+0.01%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatings iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.81Holdings in IBRN have an aggregate rating of Moderate Buy based on 360 analyst ratings issued in the past year covering 21 companies (73.8% of the portfolio).IBRN Aggregate Price Target$39.37High Prediction$39.37Average Prediction$39.37Low Prediction$39.37Holdings in IBRN have an aggregate price target of $39.37 and a range of $39.37 to $39.37 covering 21 companies (73.8% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 IBRN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.42%PRAXPraxis Precision Medicines$355.15-0.7%3.1842 of 5 stars2.95$585.95 65.0%21Positive News5.41%DNTHDianthus Therapeutics$107.85+1.5%2.1939 of 5 stars2.93$124.27 15.2%14Positive NewsInsider Trade4.78%ACADACADIA Pharmaceuticals$27.86-3.7%4.8293 of 5 stars2.78$34.36 23.3%18Positive News4.53%XENEXenon Pharmaceuticals$60.40+0.4%2.5663 of 5 stars3.00$77.13 27.7%17Positive NewsInsider Trade4.45%ARWRArrowhead Pharmaceuticals$86.49+1.3%2.1183 of 5 stars2.62$98.42 13.8%13Analyst Forecast4.45%SRRKScholar Rock$55.94-0.3%1.7867 of 5 stars3.13$58.77 5.1%16Positive News4.30%ALKSAlkermes$46.88-1.8%2.119 of 5 stars2.72$54.56 16.4%18Insider Trade4.03%BIIBBiogen$224.51+0.8%3.0646 of 5 stars2.58$228.50 1.8%33Trending NewsAnalyst Forecast3.80%PTCTPTC Therapeutics$71.40-0.5%3.7629 of 5 stars2.64$98.55 38.0%14Positive NewsAnalyst Upgrade3.64%DNLIDenali Therapeutics$22.80-0.2%3.3117 of 5 stars2.76$35.85 57.2%17Positive News3.59%ARGXargenex$1,053.46-0.2%3.8725 of 5 stars2.88$1,158.61 10.0%24Analyst Forecast3.50%NBIXNeurocrine Biosciences$158.35+0.4%4.935 of 5 stars2.88$201.05 27.0%24Positive NewsAnalyst Forecast3.47%EWTXEdgewise Therapeutics$41.95-0.1%3.4339 of 5 stars2.82$50.33 20.0%11News CoveragePositive News3.45%AXSMAxsome Therapeutics$208.35-0.7%4.212 of 5 stars2.91$267.60 28.4%22Insider Trade3.40%DYNDyne Therapeutics$24.95-0.8%3.6566 of 5 stars2.87$34.42 37.9%15News CoveragePositive News2.63%SUPNSupernus Pharmaceuticals$43.97-0.1%4.5177 of 5 stars2.71$62.83 42.9%7Positive News2.52%AXGNAxoGen$47.10-2.5%2.6293 of 5 stars2.75$51.56 9.5%12Positive News1.84%SRPTSarepta Therapeutics$22.99-0.9%2.4269 of 5 stars2.20$25.06 9.0%20Positive News1.84%BHVNBiohaven$15.90+1.3%2.3626 of 5 stars2.65$18.94 19.1%171.42%TSHATaysha Gene Therapies$5.57-1.2%2.1886 of 5 stars3.00$12.77 129.3%141.35%RAPPRapport Therapeutics$47.65-2.1%3.2591 of 5 stars3.00$62.86 31.9%13Positive News This page (NYSEARCA:IBRN) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredAre you leaving Social Security money on the table?Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....Money Pickle | SponsoredHow Long Does $2.5M Last in Retirement?Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRN Stock Alerts